Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627497 · ClinicalTrials.gov registry record · Phase 3
DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion
A Phase 3 study, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
NCT00627497 is a Phase 3 study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 32 participants.
The verdict
NCT00627497, a Phase 3 study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the safety and effectiveness of the DIAM Spinal Stabilization System as a method of treating patients with symptoms of degenerative lumbar spinal stenosis at a single level from L2 to L5.
Interventions
- PROCEDURE Single-Level Posterior Decompression
- DEVICE DIAM Spinal Stabilization
- DEVICE Fusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627497
The ClinicalTrials.gov registry entry for NCT00627497 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Single-Level Posterior Decompression is the first listed.
NCT00627497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627497 about?
NCT00627497 is a clinical study titled "DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion". The purpose of this clinical trial is to evaluate the safety and effectiveness of the DIAM Spinal Stabilization System as a method of treating patients with symptoms of degenerative lumbar spinal stenosis at a single level from L2 to L5.
What is the current status of trial NCT00627497?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2008-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00627497?
The interventions under investigation include: Single-Level Posterior Decompression (PROCEDURE), DIAM Spinal Stabilization (DEVICE), Fusion (DEVICE).
Who is sponsoring clinical trial NCT00627497?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.